Modified-Release Dipyridamole/Aspirin (200mg/25mg bd) Versus Aspirin (75mg) in Aspirin-Resistant Patients

This study has been completed.

Study NCT00129038 Information provided by Boehringer Ingelheim Pharmaceuticals

First Received: August 10, 2005 Last Updated: July 2, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	January 2007 (Final data collection date for primary outcome measure)